Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

Summary

The purpose of this study is to demonstrate the (statistical) non-inferiority of iobitridol (Xenetix® 350) when compared to contrast agents with higher iodine concentrations, iopromide (Ultravist® 370) and iomeprol (Iomeron® 400) in terms of coronary CT scan evaluability (quality and interpretability of images).

Timeline

Start

2010-11

Primary completion

2012-09

Completion

2012-09

Drugs

Indications